Use of Statistics to Assess Serious Adverse Events in Clinical Trials of New Drugs: Cross-Sectional Study of FDA Review Memos

2026-07-29

PRE

Sarah Tanveer

Peter Doshi

Tarek A. Hammad

W. C. Castillo

Linda Wastila

Catherine E. Cooke

John P. A. Ioannidis

DOI：10.1007/s11606-026-10556-7

Original request for help

Save

Abstract

IF:

4.2

Papers:

1.2W

Citations:

3.2W

Scholars:

Papers: 3

Citations: 0

Scholars:

Papers: 6

Citations: 0

Scholars:

9.2K

Papers: 3.6K

Citations: 0